Amber M. Aeilts

Amber M. Aeilts studies how inherited mutations in genes such as BRCA1, BRCA2, and PALB2 affect the risk of breast, ovarian, endometrial, pancreatic, and other cancers. Much of this work uses large patient registries to examine how factors like hormone therapy, contraception, pregnancy, breastfeeding, and physical activity influence cancer risk in people who carry these mutations. The research is aimed at improving risk prediction and prevention guidance for individuals with hereditary cancer predisposition.

Publication output was minimal before 2022 but rose sharply from 2023 onward, with output remaining high (20-36 papers/year) through 2025, suggesting a period of rapid growth followed by a sustained high level of activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026